Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety.
暂无分享,去创建一个
M. van Kleef | A. Kessels | N. Schaper | E. Joosten | I. Merkies | C. Faber | W. Pluijms | R. Slangen
[1] T. Le,et al. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain , 2009, BMC neurology.
[2] H. Buschman,et al. Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy. , 2009, Journal of diabetes and its complications.
[3] P. House. The Effects of Spinal Cord Stimulation in Neuropathic Pain Are Sustained: A 24-Month Follow-up of the Prospective Randomized Controlled Multicenter Trial of the Effectiveness of Spinal Cord Stimulation , 2009 .
[4] David Cella,et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. , 2008, The journal of pain : official journal of the American Pain Society.
[5] M. van Kleef,et al. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. , 2008, Journal of neurosurgery.
[6] E. Buchser,et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome , 2007, Pain.
[7] J. Wernicke,et al. An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain. , 2007, Pain medicine.
[8] D. Zochodne. Diabetes mellitus and the peripheral nervous system: Manifestations and mechanisms , 2007, Muscle & nerve.
[9] M. Rowbotham,et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. , 2007, Clinical therapeutics.
[10] J. Wernicke,et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain , 2006, Neurology.
[11] D. Goldstein,et al. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. , 2006, Pain medicine.
[12] T. Jensen,et al. New perspectives on the management of diabetic peripheral neuropathic pain , 2006, Diabetes & vascular disease research.
[13] C. Daousi,et al. The natural history of chronic painful peripheral neuropathy in a community diabetes population , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[14] W. Cayley. Antidepressants for the treatment of neuropathic pain. , 2006, American family physician.
[15] Smriti Iyengar,et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. , 2006, Journal of palliative medicine.
[16] B. Stacey,et al. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. , 2005, The journal of pain : official journal of the American Pain Society.
[17] G. Guyatt,et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.
[18] S. Dogra,et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo‐controlled study , 2005, European journal of pain.
[19] M. Detke,et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy , 2005, Pain.
[20] C. Daousi,et al. Electrical spinal cord stimulation in the long‐term treatment of chronic painful diabetic neuropathy , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[21] D. Selvarajah,et al. Morphine, gabapentin, or their combination for neuropathic pain. , 2005, The New England journal of medicine.
[22] R. Poole,et al. Pregabalin relieves symptoms of painful diabetic neuropathy , 2004, Neurology.
[23] T. Nurmikko,et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[24] J. Rosenstock,et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial , 2004, Pain.
[25] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[26] M. van Kleef,et al. The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: Two years' follow‐up of the randomized controlled trial , 2004, Annals of neurology.
[27] N. Harris,et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography , 1993, Diabetologia.
[28] D. Greene,et al. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat , 1993, Diabetologia.
[29] A. Gordon,et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy , 2003, Pain.
[30] R. Portenoy,et al. Controlled-release oxycodone for pain in diabetic neuropathy , 2003, Neurology.
[31] E. Davidson,et al. Preventing Superoxide Formation in Epineurial Arterioles of the Sciatic Nerve from Diabetic Rats Restores Endothelium-dependent Vasodilation , 2003, Free radical research.
[32] Sharon M. Watanabe. Lamotrigine reduces painful diabetic neuropathy : a randomized , controlled study , 2003 .
[33] A. Boulton,et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[34] Paul J Thornalley. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. , 2002, International review of neurobiology.
[35] H C de Vet,et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. , 2000, The New England journal of medicine.
[36] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[37] S. Geerlings,et al. Immune dysfunction in patients with diabetes mellitus (DM). , 1999, FEMS immunology and medical microbiology.
[38] A. Beydoun,et al. Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial , 1999 .
[39] S. Basili,et al. Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. , 1997, Metabolism: clinical and experimental.
[40] S. Tesfaye,et al. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy , 1996, The Lancet.
[41] R. Nath,et al. Spinal cord stimulation for chronic pain in peripheral neuropathy. , 1996, Surgical neurology.
[42] F. A. Gries,et al. The Epidemiology of Diabetic Neuropathy , 1993 .
[43] M. Spüler,et al. The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. , 1992, Journal of diabetes and its complications.
[44] H. Beck-Nielsen,et al. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. , 1990, British journal of clinical pharmacology.
[45] K. Brøsen,et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms , 1990, Pain.
[46] A. Wilson,et al. Sural nerve oxygen tension in diabetes. , 1986, British medical journal.
[47] A. Boulton,et al. Continuous Subcutaneous Insulin Infusion in the Management of Painful Diabetic Neuropathy , 1982, Diabetes Care.